Transcatheter aortic valve replacement (TAVR) for the treatment symptomatic severe aortic stenosis (AS) is indicated in patients with intermediate or higher surgical risk. The latest trials have shown that TAVR… Click to show full abstract
Transcatheter aortic valve replacement (TAVR) for the treatment symptomatic severe aortic stenosis (AS) is indicated in patients with intermediate or higher surgical risk. The latest trials have shown that TAVR and surgical aortic valve replacement (SAVR) perform similarly at 1 year for the
               
Click one of the above tabs to view related content.